Clinical Trial Results:
OPEN LABEL, MULTI-CENTER, PHASE 2 STUDY OF KOS-1584 IN PATIENTS
WITH ADVANCED OR METASTATIC STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
PREVIOUSLY TREATED WITH FIRST-LINE CHEMOTHERAPY
Summary
|
|
EudraCT number |
2007-006193-29 |
Trial protocol |
DE |
Global completion date |
28 Nov 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
18 Aug 2022
|
First version publication date |
18 Aug 2022
|
Other versions |
|
Summary report(s) |
KOS-1584-203 CSR Synopsis |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.